Document:

Exhibit 4.1

 

	NUMBER

U-__________	 	UNITS
	 	 	 
	SEE REVERSE FOR

CERTAIN

DEFINITIONS	EUCRATES BIOMEDICAL ACQUISITION CORP.	 

 

CUSIP ___________

UNITS CONSISTING OF
ONE ORDINARY SHARE AND

ONE-THIRD OF ONE WARRANT, EACH WHOLE WARRANT ENTITLING THE HOLDER

 TO PURCHASE ONE SHARE OF CLASS A COMMON STOCK

THIS CERTIFIES THAT
_____________________________________________ is the owner of ______________________________________________________________ Units.
Each Unit (“Unit”) consists of one (1) ordinary share, no par value per share, of EUCRATES ACQUISITION CORP., a British
Virgin Islands company (the “Company”), and one-third (1/3) one (1) warrant (each whole warrant exercisable for one
ordinary share) (a “Warrant”). Each whole Warrant entitles the holder to purchase one (1) ordinary share (subject to
adjustment) for $11.50 per share (subject to adjustment). Only whole Warrants are exercisable. Each Warrant will become exercisable
commencing on the later of (a) one year from the date of the final prospectus relating to the Company’s initial public offering
(the “Final Prospectus”) and (b)  thirty (30) days after the Company’s
completion of an acquisition, share exchange, share reconstruction and amalgamation, contractual control arrangement or other similar
business combination with one or more businesses or entities (a “Business Combination”) and will expire unless exercised
before 5:00 p.m., New York City Time, five years after the completion by Company of an initial Business Combination (the “Expiration
Date”). The ordinary share and Warrants comprising the Units represented by this certificate are not transferable separately
prior to the fifty-second (52nd) day after the date of the Final Prospectus, unless Stifel, Nicolaus & Company, Incorporated
and H.C. Wainwright & Co., LLC determine that an earlier date is acceptable, subject to certain conditions described in the
Final Prospectus. The terms of the Warrants are governed by a Warrant Agreement, dated as of _______, 2020, between the Company
and Continental Stock Transfer & Trust Company, as Warrant Agent, and are subject to the terms and provisions contained therein,
all of which terms and provisions the holder of this certificate consents to by acceptance hereof. A copy of the Warrant Agreement
is on file at the office of the Warrant Agent at 1 State Street, 30th Floor, New York, New York 10004, and are available
to any Warrant holder on written request and without cost.

 

This certificate
is not valid unless countersigned by the Transfer Agent and Registrar of the Company. This certificate shall be governed by and
construed in accordance with the internal laws of the State of New York.

 

Witness the facsimile
seal of the Company and the facsimile signatures of its duly authorized officers.

 

     

     

    

 

	By	 	SEAL	 
	 	Chief Executive Officer	2020	Chief Financial Officer

EUCRATES
BIOMEDICAL ACQUISITION CORP.

The Company will
furnish without charge to each unitholder who so requests, a statement of the powers, designations, preferences and relative, participating,
optional or other special rights of each class of shares or series thereof of the Company and the qualifications, limitations,
or restrictions of such preferences and/or rights.

 

The following abbreviations,
when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according
to applicable laws or regulations:

 

	TEN COM –	as tenants in common	UNIF GIFT MIN ACT –	_____ Custodian ______
	TEN ENT –	as tenants by the entireties	 	(Cust) (Minor)
	JT TEN –	as joint tenants with right of survivorship and not as tenants in common	 	under Uniform Gifts to Minors and not as tenants in common Act

______________
	 	 	 	(State)

 

Additional Abbreviations may also be used though not in the
above list.

For value received,
___________________________ hereby sell, assign and transfer unto

 

PLEASE INSERT SOCIAL SECURITY OR OTHER

IDENTIFYING NUMBER
OF ASSIGNEE

	 
	(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS,

INCLUDING ZIP CODE, OF ASSIGNEE)
	 

Units represented by the within Certificate,
and do hereby irrevocably constitute and appoint_______________________________________________________________________Attorney
to transfer the said Units on the books of the within named Company will full power of substitution in the premises.

 

	Dated	 	 	 
	 	 	 	Notice:	The signature to this assignment must correspond with the name as written upon the face of the certificate in every particular, without alteration or enlargement or any change whatever.

 

    2 

     

    

 

Signature(s) Guaranteed:

 

 

THE SIGNATURE(S) MUST BE GUARANTEED
BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN
APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 UNDER THE SECURITIES ACT OF 1933, AS AMENDED).

 

In each case, as more fully described
in the Company’s Final Prospectus, the holder of this certificate shall be entitled to receive funds from the trust fund
only in the event of the Company’s required redemption upon failure to consummate a business combination or if the holder
seeks to redeem its shares upon consummation of such business combination or in connection with certain amendments to the Company’s
Amended and Restated Memorandum and Articles of Association. In no other circumstances shall the holder have any right or interest
of any kind in or to the trust fund.

 

 

    3Exhibit 4.2

 

Share certificate

	Number of certificate	 	Number of shares
	 	 	 
	 	 	 

 

EUCRATES
BIOMEDICAL ACQUISITION CORP.

 

Company
number 2042314

 

(COMPANY)

 

INCORPORATED
UNDER THE BVI BUSINESS COMPANY ACT, 2004, AS AMENDED

 

This is to certify that __________________
of ________________________________________________ is the registered holder of ________________________ ordinary shares of no
par value each being fully paid in the above-named company, subject to the memorandum and articles of association of the company.

 

Given under the Common Seal of the Company
this _________________________________

 

	 	 
	DirectorEXHIBIT 4.3

 

Form of Warrant Certificate

 

[FACE]

 

Number

 

Warrants

 

THIS WARRANT SHALL BE NULL AND VOID
IF NOT EXERCISED PRIOR TO

THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR

IN THE WARRANT AGREEMENT DESCRIBED BELOW

 

Eucrates Biomedical Acquisition Corp.

Incorporated Under the Laws of the British Virgin Islands

 

CUSIP [•]

 

Warrant Certificate

 

This Warrant Certificate certifies that
                    ,
or registered assigns, is the registered holder of                     
warrant(s) evidenced hereby (the “Warrants” and each, a “Warrant”) to purchase ordinary
shares, no par value (“Shares”), of Eucrates Biomedical Acquisition Corp., a British Virgin Islands company
(the “Company”). Each Warrant entitles the holder, upon exercise during the period set forth in the Warrant
Agreement referred to below, to receive from the Company that number of fully paid and non-assessable Shares as set forth below,
at the exercise price (the “Exercise Price”) as determined pursuant to the Warrant Agreement, payable in lawful
money (or through “cashless exercise” as provided for in the Warrant Agreement) of the United States of America upon
surrender of this Warrant Certificate and payment of the Exercise Price at the office or agency of the Warrant Agent referred
to below, subject to the conditions set forth herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate
but not defined herein shall have the meanings given to them in the Warrant Agreement.

 

Each whole Warrant is initially exercisable
for one fully paid and non-assessable Share. No fractional shares will be issued upon exercise of any Warrant. If, upon the exercise
of Warrant, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down
to the nearest whole number of the number of Shares to be issued to the holder. The number of Shares issuable upon exercise of
the Warrants is subject to adjustment upon the occurrence of certain events as set forth in the Warrant Agreement.

 

The initial Exercise Price per Share for
any Warrant is equal to $11.50 per whole share. The Exercise Price is subject to adjustment upon the occurrence of certain events
as set forth in the Warrant Agreement.

 

Subject to the conditions set forth in
the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end
of such Exercise Period, such Warrants shall become null and void.

 

Reference is hereby made to the further
provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have
the same effect as though fully set forth at this place.

 

This Warrant Certificate shall not be valid
unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.

 

This Warrant Certificate shall be governed
by and construed in accordance with the internal laws of the State of New York.

 

    

     

    

 

	 	EUCRATES BIOMEDICAL ACQUISITION CORP.

 

	 	By:	 
	 	 	Name:
	 	 	Title:

 

	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS WARRANT AGENT

 

	 	By:	 
	 	 	Name:
	 	 	Title:

 

    

     

    

 

[Form of Warrant Certificate]

 

[Reverse]

 

The Warrants evidenced by this Warrant
Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive             
Shares and are issued or to be issued pursuant to a Warrant Agreement dated as of [•], 2020 (the “Warrant Agreement”),
duly executed and delivered by the Company to Continental Stock Transfer & Trust Company, a New York corporation, as
warrant agent (or successor warrant agent) (collectively, the “Warrant Agent”), which Warrant Agreement is
hereby incorporated by reference in and made a part of this instrument and is hereby referred to for a description of the rights,
limitation of rights, obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words
 “holders” or “holder” meaning the Registered Holders or Registered Holder, respectively)
of the Warrants. A copy of the Warrant Agreement may be obtained by the holder hereof upon written request to the Company. Defined
terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

 

Warrants may be exercised at any time during
the Exercise Period set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise
them by surrendering this Warrant Certificate, with the form of Election to Purchase set forth hereon properly completed and executed,
together with payment of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise”
as provided for in the Warrant Agreement) at the designated office(s) of the Warrant Agent. In the event that upon any exercise
of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby,
there shall be issued to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number of Warrants
not exercised.

 

Notwithstanding anything else in this Warrant
Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement
covering the Shares to be issued upon exercise is effective under the Securities Act and (ii) a prospectus thereunder relating
to the Shares is current, except through “cashless exercise” as provided for in the Warrant Agreement.

 

The Warrant Agreement provides that upon
the occurrence of certain events the number of Shares issuable upon exercise of the Warrants set forth on the face hereof may,
subject to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a
fractional interest in a Share, the Company shall, upon exercise, round down to the nearest whole number of Shares to be issued
to the holder of the Warrant.

 

Warrant Certificates, when surrendered
at the designated office(s) of the Warrant Agent by the Registered Holder thereof in person or by legal representative or
attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement,
but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in
the aggregate a like number of Warrants.

 

Upon due presentation for registration
of transfer of this Warrant Certificate at the office(s) of the Warrant Agent a new Warrant Certificate or Warrant Certificates
of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange
for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any tax
or other third-party charges imposed in connection therewith.

 

The Company and the Warrant Agent may deem
and treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any
notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to
the holder(s) hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any
notice to the contrary. Neither the Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a stockholder
of the Company.

 

    

     

    

 

Election to Purchase

 

(To Be Executed Upon Exercise of Warrant)

 

The undersigned hereby irrevocably elects
to exercise the right, represented by this Warrant Certificate, to receive             
Shares and herewith tenders payment for such Shares to the order of Panacea Acquisition Corp. (the “Company”)
in the amount of $                    
in accordance with the terms hereof. The undersigned requests that a certificate for such Shares be registered in the name of
                     , whose
address is                     
and that such Shares be delivered to whose address is                     .
If said number of Shares is less than all of the Shares purchasable hereunder, the undersigned requests that a new Warrant Certificate
representing the remaining balance of such Shares be registered in the name of                     ,
whose address is                     ,
and that such Warrant Certificate be delivered to                     ,
whose address is                     .

 

In the event that the Warrant has been
called for redemption by the Company pursuant to Section 6.1 or Section 6.2 of the Warrant Agreement and
the Company has required cashless exercise pursuant to Section 6.4 of the Warrant Agreement, the number of Shares
that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(b) and Section 6.4
of the Warrant Agreement.

 

In the event that the Warrant is a Private
Placement Warrant that is to be exercised on a “cashless” basis pursuant to subsection 3.3.1(c) of the
Warrant Agreement, the number of Shares that this Warrant is exercisable for shall be determined in accordance with subsection
3.3.1(c) of the Warrant Agreement.

 

In the event that the Warrant is to be
exercised on a “cashless” basis pursuant to Section 7.4 of the Warrant Agreement, the number of Shares
that this Warrant is exercisable for shall be determined in accordance with Section 7.4 of the Warrant Agreement.

 

In the event that the Warrant may be exercised,
to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number of Shares that this Warrant is exercisable
for would be determined in accordance with the relevant section of the Warrant Agreement which allows for such cashless exercise
and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise the right,
represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive Shares.
If said number of Shares is less than all of the Shares purchasable hereunder (after giving effect to the cashless exercise),
the undersigned requests that a new Warrant Certificate representing the remaining balance of such Shares be registered in the
name of                     ,
whose address is                     ,
and that such Warrant Certificate be delivered to                     ,
whose address is                     .

 

	Date: ,	 	(Signature)	 
	 	 	 
	 	 	(Address)	 
	 	 	 
	 	 	(Tax Identification Number)
	 	 	 
	Signature Guaranteed:	 	 
	 	 	 
	 	 	 
	 	 	 

 

THE SIGNATURE(S) SHOULD BE GUARANTEED
BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN
AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO SEC RULE 17Ad-15 (OR ANY SUCCESSOR RULE) under
the SECURITIES exchange act, OF 1934, AS AMENDED).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}]]